• HOME
  • SITE LINKS
    • About
    • Team
    • Privacy Policy
    • Terms & Conditions
    • Copyright
    • Advertise With Us
  • News
  • Disability
  • Education
  • Human Rights
  • Women
  • COVID-19
  • Opportunities
  • MORE
    • Opinion
    • Politics
    • Finance
    • Youths
    • Crime
    • Technology
    • International
    • Girls
    • Health
  • Contact
Menu
  • HOME
  • SITE LINKS
    • About
    • Team
    • Privacy Policy
    • Terms & Conditions
    • Copyright
    • Advertise With Us
  • News
  • Disability
  • Education
  • Human Rights
  • Women
  • COVID-19
  • Opportunities
  • MORE
    • Opinion
    • Politics
    • Finance
    • Youths
    • Crime
    • Technology
    • International
    • Girls
    • Health
  • Contact
Search
Close
Home News COVID-19

COVID19: FG Approves N10 Billion for Local Vaccine Production No ratings yet.

Isaiah Ude by Isaiah Ude
January 19, 2021
in COVID-19
1
A gloved hand holding a transparent bottle (with the middle finger at the top and thumb at the bottom) containing a liquid in it. Covid-19 vaccine is written on the bottle
0
SHARES
30
VIEWS
FacebookTwitterWhatsAppMail

The Federal Ministry of Finance has released N10 billion to support local COVID19 vaccine production in Nigeria.

This was disclosed by the Minister of Health, Dr Osagie Ehanire at the Presidential Task Force (PTF) COVID-19 media briefing.

Ehanire said: “The Ministry of Finance has released N10 billion to support domestic vaccine production”

“While we are working to develop our own vaccines, Nigeria is exploring options for licensed production, in collaboration with recognised institutions.

We are also exploring the option of local production of the vaccines in the country.”

Ehanire urged Nigerians to ignore claims by some people that they had COVID-19 vaccines for sale in the country.

“I advise all citizens to disregard these claims, as they are criminal. There are procedures for vaccine acquisition and use, which include appropriate regulations and certification by the National Agency for Food and Drug and Administration and Control (NAFDAC).

Ehanire also explained that the first consignment of vaccine doses will arrive within weeks, and will cover 20 per cent of the population, but added that there are plans to increase the figure to cover 50 per cent.

On vaccines, he said “we are exploring all options available for the acquisition of approved vaccines for Nigerians. We are hopeful that the first consignment will arrive in the country in some weeks.

He reiterated that reducing infection rate for COVID-19 remained the easiest and cheapest objective of the government.

According to him, government’s main effort is to ensure social mobilisation for testing, strengthening surveillance activities for early detection, active contact tracing, isolation and treatment.

He, however, added that the implementation of critical non-pharmaceutical measures required the cooperation of the public.
“This includes much more adherence to wearing masks, social distancing, use of sanitiser, etc. than we are seeing today. Of special concern are the so-called “super spreader activities” that involve congregational settings, which must be reduced, restricted or prohibited in the interest of the common good.

Please rate this

Tags: COVID19Vaccine

Search Posts

No Result
View All Result

BONews Service

BONews is an online development news platform with focus on Women, Persons with Disabilities and Children. BONews contents span across Education, Health and impact-driven reports on all our focus areas.

Follow us

Facebook-f Twitter Linkedin Youtube

Browse by Category

  • News
  • Girls
  • Health
  • Women
  • Education
  • International
  • Book & Arts
  • Finance
  • Politics
  • Technology
  • Crime
  • COVID-19
  • Disability
  • Court
  • Human Rights
  • Military
  • Election
  • Security
  • Police
  • Judiciary
  • Corruption
  • Climate Change

Newsletter

Subscribe to our mailing list to receive daily updates direct to your inbox!

  • © 2020 BONews All rights reserved
  • Copyright
  • Terms & Conditions
  • Privacy Policy
  • Team